Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the ...

The highly competitive, $100,000 award supports mission-driven graduate students working toward a professional or advanced ...

The school secures more than $100 million in research grants each year. Read more at straitstimes.com. Read more at ...

SHM’s Awards of Excellence program honors members who’ve made exceptional contributions to hospital medicine in various ...

Computer science teams develop new digital platforms to tackle critical gaps in EMS training and mass casualty response ...

Scientists and public health advocates see disconnects between what the Trump administration says about health — notably, in ...

The most powerful public health official in the US is reviled by some medics - but even some of his critics accept that he is ...

New study details gaps between actual and recommended use of statins and other lipid-lowering drugs—and estimates public ...

From Nobel laureates to AI-driven research, the Wilmer Eye Institute honors a century of transforming vision science and care ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...